CL2009000490A1 - Procesos de preparacion de (fenilsulfanilfenil)piperidinas a partir de una n-bencil-piperidona; los intermediarios considerados; y la preparacion de uno de ellos. - Google Patents
Procesos de preparacion de (fenilsulfanilfenil)piperidinas a partir de una n-bencil-piperidona; los intermediarios considerados; y la preparacion de uno de ellos.Info
- Publication number
- CL2009000490A1 CL2009000490A1 CL2009000490A CL2009000490A CL2009000490A1 CL 2009000490 A1 CL2009000490 A1 CL 2009000490A1 CL 2009000490 A CL2009000490 A CL 2009000490A CL 2009000490 A CL2009000490 A CL 2009000490A CL 2009000490 A1 CL2009000490 A1 CL 2009000490A1
- Authority
- CL
- Chile
- Prior art keywords
- preparation
- phenylsulfanylphenyl
- piperidone
- intermediaries
- piperidines
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- NUVVEDILYSTVDX-UHFFFAOYSA-N 1-(2-phenylsulfanylphenyl)piperidine Chemical class C1CCCCN1C1=CC=CC=C1SC1=CC=CC=C1 NUVVEDILYSTVDX-UHFFFAOYSA-N 0.000 title 1
- MLEGMEBCXGDFQT-UHFFFAOYSA-N 1-benzylpiperidin-2-one Chemical compound O=C1CCCCN1CC1=CC=CC=C1 MLEGMEBCXGDFQT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 (phenyl-sulfanyl-phenyl) piperidine Chemical class 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200800314 | 2008-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2009000490A1 true CL2009000490A1 (es) | 2010-04-16 |
Family
ID=40547924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2009000490A CL2009000490A1 (es) | 2008-03-03 | 2009-03-02 | Procesos de preparacion de (fenilsulfanilfenil)piperidinas a partir de una n-bencil-piperidona; los intermediarios considerados; y la preparacion de uno de ellos. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8362255B2 (enExample) |
| EP (1) | EP2260024B1 (enExample) |
| JP (1) | JP5564439B2 (enExample) |
| KR (1) | KR20100122914A (enExample) |
| CN (1) | CN101959859B (enExample) |
| AR (1) | AR070737A1 (enExample) |
| AT (1) | ATE539055T1 (enExample) |
| AU (1) | AU2009221170B2 (enExample) |
| BR (1) | BRPI0908166A2 (enExample) |
| CA (1) | CA2715579A1 (enExample) |
| CL (1) | CL2009000490A1 (enExample) |
| CO (1) | CO6290758A2 (enExample) |
| CY (1) | CY1113887T1 (enExample) |
| DK (1) | DK2260024T3 (enExample) |
| EA (1) | EA017855B1 (enExample) |
| ES (1) | ES2377862T3 (enExample) |
| HR (1) | HRP20120118T1 (enExample) |
| IL (1) | IL207471A (enExample) |
| MX (1) | MX2010008729A (enExample) |
| NZ (1) | NZ587593A (enExample) |
| PL (1) | PL2260024T3 (enExample) |
| PT (1) | PT2260024E (enExample) |
| RS (1) | RS52128B (enExample) |
| SI (1) | SI2260024T1 (enExample) |
| TW (1) | TW200940505A (enExample) |
| UA (1) | UA98698C2 (enExample) |
| WO (1) | WO2009109541A1 (enExample) |
| ZA (1) | ZA201006135B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007260356B2 (en) * | 2006-06-16 | 2013-01-24 | H. Lundbeck A/S | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| JP2012163850A (ja) * | 2011-02-08 | 2012-08-30 | Nippon Sheet Glass Co Ltd | 正立等倍レンズアレイプレート、光走査ユニット、画像読取装置および画像書込装置 |
| AP2014008046A0 (en) | 2012-05-21 | 2014-11-30 | Novartis Ag | Novel ring-substituted N-pyridinyl amides as kinase inhibitors |
| CN104710345B (zh) * | 2013-12-17 | 2017-09-05 | 江苏恩华药业股份有限公司 | 用于制备4‑（2‑（4‑甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2324087A (en) * | 1997-04-10 | 1998-10-14 | Merck & Co Inc | Preparation of (S)-3-Carbethoxy-3-benzylpiperidine |
| WO2001046147A1 (en) | 1999-12-20 | 2001-06-28 | Eli Lilly And Company | A process for preparing 4-substituted piperidines |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| UA81300C2 (en) * | 2003-04-04 | 2007-12-25 | Lundbeck & Co As H | Derivates of 4-(2-fenilsulfanilfenil)-1,2,3,6-tetrahydropiridin as retarding agents of serotonin recapture |
| AU2004226838B8 (en) * | 2003-04-04 | 2009-06-11 | H. Lundbeck A/S | 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
| AU2007260356B2 (en) * | 2006-06-16 | 2013-01-24 | H. Lundbeck A/S | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
-
2009
- 2009-02-03 UA UAA201011031A patent/UA98698C2/ru unknown
- 2009-02-19 TW TW098105235A patent/TW200940505A/zh unknown
- 2009-03-02 DK DK09717792.7T patent/DK2260024T3/da active
- 2009-03-02 EP EP09717792A patent/EP2260024B1/en active Active
- 2009-03-02 CN CN200980108235XA patent/CN101959859B/zh not_active Expired - Fee Related
- 2009-03-02 ES ES09717792T patent/ES2377862T3/es active Active
- 2009-03-02 CA CA2715579A patent/CA2715579A1/en not_active Abandoned
- 2009-03-02 WO PCT/EP2009/052440 patent/WO2009109541A1/en not_active Ceased
- 2009-03-02 NZ NZ587593A patent/NZ587593A/en not_active IP Right Cessation
- 2009-03-02 AR ARP090100734A patent/AR070737A1/es unknown
- 2009-03-02 SI SI200930184T patent/SI2260024T1/sl unknown
- 2009-03-02 KR KR1020107019480A patent/KR20100122914A/ko not_active Ceased
- 2009-03-02 US US12/920,357 patent/US8362255B2/en not_active Expired - Fee Related
- 2009-03-02 CL CL2009000490A patent/CL2009000490A1/es unknown
- 2009-03-02 AT AT09717792T patent/ATE539055T1/de active
- 2009-03-02 PT PT09717792T patent/PT2260024E/pt unknown
- 2009-03-02 RS RS20120063A patent/RS52128B/sr unknown
- 2009-03-02 HR HR20120118T patent/HRP20120118T1/hr unknown
- 2009-03-02 JP JP2010549114A patent/JP5564439B2/ja not_active Expired - Fee Related
- 2009-03-02 PL PL09717792T patent/PL2260024T3/pl unknown
- 2009-03-02 BR BRPI0908166-6A patent/BRPI0908166A2/pt not_active IP Right Cessation
- 2009-03-02 AU AU2009221170A patent/AU2009221170B2/en not_active Ceased
- 2009-03-02 MX MX2010008729A patent/MX2010008729A/es active IP Right Grant
- 2009-03-02 EA EA201071025A patent/EA017855B1/ru not_active IP Right Cessation
-
2010
- 2010-08-08 IL IL207471A patent/IL207471A/en not_active IP Right Cessation
- 2010-08-27 ZA ZA2010/06135A patent/ZA201006135B/en unknown
- 2010-09-02 CO CO10108740A patent/CO6290758A2/es active IP Right Grant
-
2012
- 2012-02-13 CY CY20121100145T patent/CY1113887T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009001044A1 (es) | Compuestos cristalinos derivados de heterociclos puenteados por un alqueno; utiles en el tratamiento de enfermedades metabolicas, enfermedades circulatorias, enfermedades del snc, entre otras enfermedades. | |
| ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
| GEP20125666B (en) | HYDROXYMETHYL PYRROLIDINES AS β3 ADRENERGIC RECEPTOR AGONISTS | |
| BRPI0920914A8 (pt) | Perácidos alfa-ceto e métodos para produzir e usar os mesmos. | |
| PE20120602A1 (es) | ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA | |
| CL2008000899A1 (es) | Compuestos derivados de 3-imidazolil-indolilo, inhibidores de la interaccion entre p53 y mdm2 y/o mdm4; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento y/o profilaxis de enfermedades proliferativas. | |
| ECSP11011079A (es) | Nuevos compuestos de hidroxiareno. | |
| NO20084850L (no) | MGLUR5 modulatorer I | |
| CO6511251A2 (es) | Compuestos quimicos | |
| CL2008000434A1 (es) | Compuestos derivados de 2-amino-oxazolinas; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, estres, trastorno bipolar, entre otros. | |
| MX2012003539A (es) | Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac). | |
| ECSP078060A (es) | 2,4-diamino-pirimidinas como inhibidores de aurora | |
| EA201200741A1 (ru) | Способ получения этексилата дабигатрана | |
| ECSP066373A (es) | Forma cristalina beta de clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen | |
| EA201001402A1 (ru) | Фармацевтические растворы, способ получения и терапевтическое применение | |
| CL2008002268A1 (es) | Compuestos derivados de amidas, moduladores del receptor taar1; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, estres, entre otros. | |
| GEP20135863B (en) | Substituted piperidines as ccr3 antagonists | |
| BR112012008020B8 (pt) | máquina de perfuração. | |
| EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
| MX2012004311A (es) | Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes. | |
| CR8246A (es) | Forma cristalina gamma-d del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que las contienen | |
| CL2010000281A1 (es) | Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion. | |
| CL2009000490A1 (es) | Procesos de preparacion de (fenilsulfanilfenil)piperidinas a partir de una n-bencil-piperidona; los intermediarios considerados; y la preparacion de uno de ellos. | |
| CU24011B1 (es) | Piperidinas 2-fenil-5-(1,2,4-oxadiazol-5-il) sustituidas | |
| CL2011003123A1 (es) | Compuestos derivados de ciclopentanamida sustituidos; composicion farmaceutica; proceso de obtencion; y uso en el tratamiento o la profilaxis de la diabetes, aterosclerosis, entre otras. |